Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.
<h4>Introduction</h4>The low incidence of oesophageal adenocarcinoma (EAC) in Barrett's oesophagus (BE) patients reinforces the need for risk stratification tools to make BE surveillance more effective. Therefore, we have undertaken a systematic review and meta-analysis of published...
Saved in:
| Main Authors: | Vincent T Janmaat, Sophie H van Olphen, Katharina E Biermann, Leendert H J Looijenga, Marco B Bruno, Manon C W Spaander |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0186305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-reflux surgical treatment for Barrett’s oesophagus
by: B. F. Shevchenko, et al.
Published: (2022-02-01) -
STENTING OF THE OESOPHAGUS AND OESOPHAGEAL ANASTOMOSES IN THE CASE OF NEOPLASTIC STENOSIS
by: V. N. Novikov, et al.
Published: (2018-01-01) -
The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus
by: Wojciech Polkowski, et al.
Published: (2003-01-01) -
The prevalence of, and risk factors for, Barrett’s oesophagus after sleeve gastrectomy
by: Marcin Migaczewski, et al.
Published: (2021-07-01) -
Developing patient-orientated Barrett’s oesophagus services: the role of dedicated services
by: John McLaughlin, et al.
Published: (2022-11-01)